EFFICACY OF NEWER GLP-1 RECEPTOR AGONISTS ON NON-ALCOHOLIC FATTY LIVER DISEASE IN TYPE 2 DIABETES. The Research of Medical Science Review, [S. l.], v. 3, n. 5, p. 290–294, 2025. Disponível em: http://thermsr.com/index.php/Journal/article/view/1109.. Acesso em: 14 may. 2025.